Tumor Marker tests are essential diagnostic tools used to detect and monitor various cancers. These tests measure specific substances in the blood, urine, or tissues that indicate cancer presence, progression, or recurrence.
Common tumor markers include PSA for prostate cancer, CEA for colorectal cancer, AFP for liver cancer, CA 19-9 for pancreatic cancer, CA 125 for ovarian cancer, and CA 15-3 for breast cancer. While these tests aid in cancer detection and treatment monitoring, they are not definitive diagnostic tools and must be interpreted alongside imaging and biopsies.
At Biocheck Diagnostics And Polyclinic, we offer advanced tumor marker testing to aid in early cancer detection, monitoring, and treatment planning. Book your tumor marker test today for accurate and timely results.
tumor Markers Test
A Tumor Marker test is a diagnostic procedure used to detect and measure specific substances—called tumor markers—that are produced by cancer cells or by normal cells in response to cancer. These markers, which can be proteins, hormones, or genetic mutations, are found in blood, urine, or tissue samples.
Tumor marker tests help doctors diagnose cancer, determine its severity, monitor treatment effectiveness, and detect cancer recurrence. While these tests are useful, they are often used in conjunction with imaging tests and biopsies for a comprehensive diagnosis.
Tumor Markers Test
Proper preparation ensures the accuracy of tumor marker tests. Here are key points to keep in mind:
Fasting Requirements - Some tumor marker tests, such as CEA (Carcinoembryonic Antigen), may require fasting. Always confirm with your doctor.
Medication Disclosure - Inform your doctor about any medications, supplements, or treatments you are undergoing, as they may affect test results.
Hydration - Drink plenty of water before the test to facilitate a smooth blood draw.
Avoid Alcohol and Smoking - Refrain from consuming alcohol and tobacco at least 24 hours before the test, as they can influence marker levels.
Timing of the Test - Certain tumor markers fluctuate throughout the day. Your doctor will recommend the best time for sample collection.
Always consult your healthcare provider for specific pre-test instructions based on your symptoms and medical history.
WHY CHOOSE Biocheck Diagnostics And Polyclinic
Our laboratory is led by a highly qualified M.D. Pathologist, ensuring that every test is interpreted with expert knowledge.
We use advanced technology and automated systems to ensure that your Tumor Markers results are accurate, reliable, and fast.
Our lab is staffed with highly trained and experienced hematologists and medical technologists who interpret and analyze your results with precision.
We prioritize your privacy. All test results are confidential and shared only with you and your healthcare provider.
At the heart of everything we do is our commitment to the patient.
We understand that healthcare costs can be a concern, which is why we offer affordable pricing for all of our Tumor Markers tests.
What Biocheck Offers
Helps diagnose and monitor liver cancer, testicular cancer, and certain non-cancerous liver diseases.
Measures total PSA levels in the blood to screen for and monitor prostate cancer.
Assesses free PSA levels to help differentiate between prostate cancer and benign conditions.
A tumor marker used to detect and monitor colorectal, lung, and other gastrointestinal cancers.
A marker primarily used for pancreatic cancer detection and monitoring treatment response.
Commonly used to detect and track ovarian cancer and assess treatment effectiveness.
A tumor marker primarily associated with breast cancer diagnosis and monitoring.
KNOW ABOUT TUMOR MARKERS
Tumor markers are primarily used in diagnosing and monitoring different types of cancers and malignancies. Elevated tumor markers may indicate cancer presence, progression, or recurrence. However, non-cancerous conditions can also cause changes in tumor marker levels, requiring further investigation.
Prostate Cancer: The Prostate-Specific Antigen (PSA) test helps in screening for prostate cancer and monitoring its progression. High PSA levels may indicate cancer, but they can also be elevated due to prostate infections or benign prostatic hyperplasia (BPH).
Colorectal & Gastrointestinal Cancers: The Carcinoembryonic Antigen (CEA) test detects cancers of the colon, rectum, pancreas, and stomach. Elevated CEA levels are often associated with cancer progression but can also rise due to inflammatory bowel diseases or smoking.
Liver Cancer: Alpha-Fetoprotein (AFP) is a key tumor marker for liver cancer (hepatocellular carcinoma) and testicular cancer. However, increased AFP levels can also be seen in cirrhosis and chronic hepatitis.
Pancreatic Cancer: Cancer Antigen 19-9 (CA 19-9) is used in diagnosing and monitoring pancreatic cancer. While elevated CA 19-9 levels can indicate malignancy, they may also be seen in gallbladder disease or chronic pancreatitis.
Ovarian Cancer: Cancer Antigen 125 (CA 125) is primarily used to detect and track ovarian cancer. Increased CA 125 levels can also occur in non-cancerous conditions like endometriosis and pelvic inflammatory disease (PID).
Breast Cancer: Cancer Antigen 15-3 (CA 15-3) is useful in monitoring breast cancer recurrence and treatment response. However, elevated levels can be found in other cancers and benign breast conditions.
Since tumor marker levels can be influenced by both malignant and benign conditions, additional tests such as biopsies, imaging scans, and clinical evaluations are necessary for a definitive cancer diagnosis.
Tumor marker tests are specialized blood or tissue tests used to detect and measure substances produced by cancerous or normal cells in response to cancer. These markers, which may be proteins, hormones, or genetic alterations, help doctors in diagnosing cancer, assessing treatment effectiveness, and monitoring for recurrence. While tumor markers are valuable diagnostic tools, they are not standalone tests; results are often interpreted alongside imaging scans and biopsies for a comprehensive evaluation.
Different tumor markers are associated with specific types of cancer. Prostate-Specific Antigen (PSA) is commonly used to screen for and monitor prostate cancer, whereas Carcinoembryonic Antigen (CEA) is a key marker for colorectal and other gastrointestinal cancers. Alpha-Fetoprotein (AFP) is helpful in detecting liver and testicular cancer, while Cancer Antigen 19-9 (CA 19-9) is often elevated in pancreatic cancer. Cancer Antigen 125 (CA 125) is used for ovarian cancer diagnosis and monitoring, and Cancer Antigen 15-3 (CA 15-3) helps track breast cancer progression. Elevated levels of tumor markers do not always indicate cancer, as benign conditions can also cause fluctuations, making additional confirmatory tests necessary.
Tumor marker tests play a crucial role in cancer management by helping oncologists tailor treatments, predict disease progression, and detect relapses early. Regular monitoring of tumor markers during and after treatment provides valuable insights into a patient’s response to therapy. However, since tumor marker levels can be influenced by non-cancerous conditions, medical professionals always correlate test results with clinical findings for accurate diagnosis and decision-making.
MAKE APPOINTMENTS
